Newsroom
Sorted by: Latest
-
タンジェMED港、日本企業に向けてモロッコの産業および投資機会を紹介
大阪&東京--(BUSINESS WIRE)--(ビジネスワイヤ) -- タンジェMED港と株式会社三井住友銀行(SMBC)は、住友商事の後援を受けて「Japan Roadshow 2026」 を主催し、大阪および東京において商談会を開催しました。この取り組みは、タンジェMEDに集約されている港湾・物流・産業の拠点における投資機会を紹介するとともに、特に自動車、航空宇宙、電子機器、物流、再生可能エネルギーの各分野における貿易および産業協力を促進し、モロッコと日本の経済・産業面での結びつきを強化することを狙いとしています。 この訪日旅行商談会は、サプライチェーンの統合、技術移転、持続可能な製造を促進する一方で、日本を代表する企業との直接的なやり取りや商談の円滑化の後押しとなりました。 タンジェMED港は、東西を結ぶ主要な海上航路の交差点であるジブラルタル海峡に位置し、欧州、アフリカをはじめとする世界各地の市場へのアクセスを提供しています。世界180以上の港を繋ぐタンジェMEDの港湾複合施設における2025年の貨物取扱高は1,110万TEU超、1億6,100万トンにのぼり、アフリカおよび...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-
Tanger Med Showcases Morocco's Industrial and Investment Opportunities to Japanese Businesses
OSAKA, Japan & TOKYO--(BUSINESS WIRE)--Tanger Med Showcases Morocco's Industrial and Investment Opportunities to Japanese Businesses...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 12.11.2026 FVD. IE00BKVKW020 200,002.00 USD 6,345,963.56 31.730 ...
-
Billboard and VENU Honor Jorge Juárez with ‘Disruptor Award’ at Billboard Live Music Summit in Los Angeles
LOS ANGELES--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment venues and hospitality destinations, and Billboard, the global authority in music, announced that Jorge Juárez, CEO of Westwood Entertainment and founder of Novus Media, has been awarded Billboard’s ‘Disruptor Award’ presented by VENU®. Widely recognized for helping carry Música Mexicana to some of the world’s biggest stages, Juár...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 12.11.2026 FTCS. IE00BL0L0D23 200,002.00 USD 7,296,132.68 36.480 ...
-
Ontada Advances the Intelligent Medical Record with Integrated AI Capabilities for iKnowMed
BOSTON--(BUSINESS WIRE)--Ontada, a business dedicated to transforming community oncology through technology, announced new AI capabilities are available to iKnowMed customers....
-
TIAA-CREF UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Teachers Insurance and Annuity Association of America/TIAA-CREF Investment Management, LLC/ Nuveen Asset Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
-
Kontrol Technologies Announces Third Quarter 2026 Financial Results
TORONTO--(BUSINESS WIRE)--Kontrol Technologies Announces Third Quarter 2026 Financial Results...
-
Zai Lab Presents Positive First-in-Human Data for ZL-1503, a Novel IL-13/IL-31Rα Bispecific, Demonstrating Rapid and Sustained Inhibition of Key Atopic Dermatitis Biomarkers and Extended Serum Half-Life Supporting Less Frequent Dosing
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced positive preliminary, first-in-human results from the single-ascending-dose portion of its global Phase 1/1b trial of ZL-1503, an internally discovered, long-acting IL-13/IL-31 receptor alpha (Rα) bispecific antibody. Findings from the study will be presented at the American College of Allergy, Asthma & Immunology (ACAAI) 2026 Annual Scien...